Thrivent Financial for Lutherans’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82K | Hold |
70,641
| – | – | ﹤0.01% | 2414 |
|
|
2025
Q1 | $112K | Hold |
70,641
| – | – | ﹤0.01% | 2342 |
|
|
2024
Q4 | $214K | Buy |
70,641
+43,036
| +156% | +$130K | ﹤0.01% | 2502 |
|
|
2024
Q3 | $101K | Hold |
27,605
| – | – | ﹤0.01% | 2497 |
|
|
2024
Q2 | $112K | Sell |
27,605
-1,181
| -4% | -$4.79K | ﹤0.01% | 2504 |
|
|
2024
Q1 | $454K | Hold |
28,786
| – | – | ﹤0.01% | 2266 |
|
|
2023
Q4 | $436K | Sell |
28,786
-1,406
| -5% | -$21.3K | ﹤0.01% | 2242 |
|
|
2023
Q3 | $605K | Hold |
30,192
| – | – | ﹤0.01% | 2044 |
|
|
2023
Q2 | $852K | Sell |
30,192
-1,482
| -5% | -$41.8K | ﹤0.01% | 1912 |
|
|
2023
Q1 | $544K | Hold |
31,674
| – | – | ﹤0.01% | 2095 |
|
|
2022
Q4 | $638K | Hold |
31,674
| – | – | ﹤0.01% | 1995 |
|
|
2022
Q3 | $687K | Hold |
31,674
| – | – | ﹤0.01% | 1912 |
|
|
2022
Q2 | $890K | Buy |
+31,674
| New | +$890K | ﹤0.01% | 1781 |
|